Erratum to: Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential  

作　　者：Chenglong Wang Wencai Guan Rong Chen Yael Levi-Kalisman Yichun Xu Liwen Zhang Min Zhou Guoxiong Xu Hongjing Dou 

机构地区：[1]The State Key Laboratory of Metal Matrix Composites,School of Materials Science and Engineering,Shanghai Jiao Tong University,Shanghai,200240,China [2]Research Center for Clinical Research,Jinshan Hospital,Fudan University,Shanghai,200540,China [3]Department of Respiratory and Critical Care Medicine,Ruijin Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai,200025,China [4]Institute of Respiratory Diseases,School of Medicine,Shanghai Jiao Tong University,Shanghai,200025,China [5]The Center for Nanoscience and Nanotechnology and the Institute of Life Sciences,Hebrew University of Jerusalem,Jerusalem,91905,Israel [6]Shanghai Biochip Co.Ltd.and National Engineering Center for Biochip at Shanghai,Shanghai,201203,China

出　　处：《Nano Research》2021年第11期4364-4364,共1页纳米研究（英文版）

基　　金：This work was financially supported by the National Natural Science Foundation of China(Nos.21871180 and 81872121);the“Shuguang Program”supported by the Shanghai Education Development Foundation and the Shanghai Municipal Education Commission(No.17SG12);the Program for Professor of Special Appointment(Eastern Scholar)at Shanghai Institutions of Higher Learning(No.SHDP201802);the Science and Technology Commission of Shanghai Municipality(No.18520710300 and 18JC1413500);the Biomedical Interdisciplinary Research Foundation of SJTU(No.YG2019QNB34).

摘　　要：Erratum to Nano Research 2020,13(11):3110-3122 https://d0i.0rg/l 0.1007/s 12274-020-2981-8 The article Fluorescent glycan nanoparticle-based FACS assays for the identification of genuine drug-resistant cancer cells with differentiation potential,written by Chenglong Wang et al.,was erroneously originally published electronically on the publishers internet portal(currently SpringerLink)on 10 August 2020 with the Acknowledgements.

关 键 词：al. drug cancer 

分 类 号：R730[医药卫生—肿瘤] G23[医药卫生—临床医学]